Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice

International Journal of Cancer

Volumn 81, Issue 4, 1999, Pages 592-597

  Kuriyama, Shigeki ^a   Kikukawa, Masaji ^a   Masui, Kazuhiro ^a   Okuda, Hirotsugu ^a   Nakatani, Toshiya ^a   Sakamoto, Takemi ^a   Yoshiji, Hitoshi ^a   Fukui, Hiroshi ^a   Ikenaka, Kazuhiro ^b   Mullen, Craig A ^c   Tsujii, Tadasu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; HELPER CELL; IMMUNOCOMPETENCE; LIVER CELL CARCINOMA; MACROPHAGE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GENE THERAPY; GENETIC VECTORS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NUCLEOSIDE DEAMINASES; RETROVIRIDAE; TIME FACTORS;

EID: 0032930673     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990517)81:4<592::AID-IJC15>3.0.CO;2-I     Document Type: Article

References (29)

1. AUSTIN, E.A. and HUBER, B.E., A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Eschfrichia coli cytosine deaminase. Mol. Pharmacol., 43, 380-387 (1992).
2. CAO, G., KURIYAMA, S., DU, P., SAKAMOTO, T., YANG, W., MASUI, K. and QI, Z., Construction of retroviral vectors to induce strong hepatoma cell-specific expression of cytokine genes. J. Gastroenterol. Hepatol., 11, 1053-1061 (1996).
3. CONSALVO, M., MULLEN, C.A., MODESTI, A., MUSIANI, P., ALLIONE, A., CAVALLO, E, GIOVARELLI, M. and FORNI, G., 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J. Immunol., 154, 5302-5312 (1995).
4. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E. and BLAESE, R.M., In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 256, 1550-1552 (1992).
5. DANIELSEN, S., KILSTRUP, M., BARILLA, K., JOCHIMSEN, B. and NEUHARD, J., Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase. Mol. Microbiol., 6, 1335-1344 (1992).
6. DONG, Y., WEN, P., MANOME, Y., PARR, M., HIRSHOWITZ, A., CHEN, L., HIRSCHOWITZ, E.A., CRYSTAL, R., WEICHSELBAUM, R., KUFE, D.W. and FINE, H.A., In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther., 7, 713-720 (1996).
7. HIRSCHOWITZ, E.A., OHWADA, A., PASCAL, W.R., RUSSI, T.J. and CRYSTAL, R.G., In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther., 6, 1055-1063 (1995).
8. HUBER, B.E., AUSTIN, E.A., GOOD, S.S., KNICK, V.C., TIBBELS, K.S. and RICHARDS, C.A., In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deami-nase. Cancer Res., 53, 4619-4626 (1993).
9. HUBER, B.E., AUSTIN, E.A., RICHARDS, C.A., DAVIS, S.T. and GOOD, S.S., Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. nat. Acad. Sci. (Wash.), 91, 8302-8306 (1994).
10. KANAI, F., LAN, K.-H., SHIRATORI, Y., TANAKA, T., OHASHI, M., OKUDAIRA, T., YOSHIDA, Y., WAKIMOTO, H., HAMADA, H., NAKABAYASHI, H., TAMAOKI, T. and OMATA, M., In vivo gene therapy for α-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res., 57, 461-465 (1997).
11. KURIYAMA, S. and 12 OTHERS, Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil. Anticancer Res., 18, 3399-3406 (1998a).
12. KURIYAMA, S., MASUI, K., SAKAMOTO, T., NAKATANI, T., TOMINAGA, K., FUKUI, H., IKENAKA, K., MULLEN, C.A. and TSUJII, T., Bacterial cytosine deaminase suicide gene transduction renders hepatocellular carcinoma sensitive to the prodrug 5-fluorocytosine. Int. Hepatol. Comm., 4, 72-79 (1995a).
13. KURIYAMA, S., NAKATANI, T., MASUI, K., SAKAMOTO, T., TOMINAGA, K., YOSHIKAWA, M., FUKUI, H., IKENAKA, K. and TSUJII, T., Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology, 22, 1838-1846 (1995b).
14. KURIYAMA, S., SAKAMOTO, T., KIKUKAWA, M., NAKATANI, T., TOYOKAWA, Y., TSUJINOUE, H., IKENAKA, K., FUKUI, H. and TSUJII, T., Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment. Gene Ther., 5, 1299-1305 (1998b).
15. KURIYAMA, S., SAKAMOTO, T., MASUI, K., NAKATANI, T., TOMINAGA, K., KIKUKAWA, M., YOSHIKAWA, M., IKENAKA, K., FUKUI, H. and TSUJII, T., Tissue-specific expression of HSV-tk gene can induce efficient antitumor effect and protective immunity to wild-type hepatocellular carcinoma. Int. J. Cancer, 71, 470-475 (1997).
16. MARQUARDT, D.W. and SIAM, J., An algorithm for least square estimation of non-linear parameters. J. Soc. Indust. Appl. Math., 11, 431-441 (1963).
17. MILLER, A.D. and BUTTIMORE, C., Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. cell. Biol., 6, 2895-2902 (1986).
18. MOOLTEN, F.L., Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46, 5276-5281 (1986).
19. MULLEN, C.A., Metabolic suicide genes in gene therapy. Pharmacol. Ther., 63, 199-207 (1994a).
20. MULLEN, C.A., COALE, M.M., LOWE, R. and BLAESE, R.M., Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res., 54, 1503-1506 (1994b).
21. MULLEN, C.A., KILSTRUP, M. and BLAESE, R.M., Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. nat. Acad. Sci. (Wash.), 89, 33-37 (1992).
22. NISHIYAMA, T., KAWAMURA, Y., KAWAMOTO, K., MATSUMURA, H., YAMAMOTO, N., ITO, T., OHYAMA, A., KATSURAGI, T. and SAKAI, T., Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res., 45, 1753-1761 (1985).
23. OHWADA, A., HIRSCHOWITZ, E.A. and CRYSTAL, R.G., Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum. Gene Ther., 7, 1567-1576 (1996).
24. PATEK, P.Q., COLLINS, J.L. and COHN, M., Transformed cell lines suscep-tible or resistant to in vivo surveillance against tumorigenesis. Nature (Lond.), 276, 510-511 (1978).
25. RICHARDS, C.A., AUSTIN, E.A. and HUBER, B.E., Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cyto-sine deaminase for tumor-specific gene therapy. Hum. Gene Ther., 6, 881-893 (1995).
26. ROWLEY, S., LINDAUER, M., GEBERT, J.F., HABERKORN, U., OBERDORFER, F., MOEBIUS, U., HERFARTH, C. and SCHACKERT, H.-K., Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer. J. surg. Oncol, 61, 42-48 (1996).
27. SENTER, P.D., SU, P., KATSURAGI, T., SAKAI, T., COSAND, W.L., HELLSTROM, I. and HELLSTROM, K.E., Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates. Bioconjugate. Chem., 2, 447-451 (1991).
28. TSURUO, T., YAMORI, T., NAGANUMA, K., HORI, K., KAWABATA, H., TSUKAGOSHI, S. and SAKURAI, Y., Metastasis after intravenous inoculation of highly metastatic variants of mouse tumors and the effects of several antitumor drugs on the tumors. Gann, 75, 193-198 (1984).
29. UCKERT, W., KAMMERTÖNS, T., HAACK, K., QIN, Z., GEBERT, J., SCHENDEL, D.J. and BLANKENSTEIN, T., Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum. Gene Ther., 9, 855-865 (1998).